Advances in mood stabilizing medications.
B J
BJ
Blinder
S
S
Bhat
V A
VA
Sanathara
D000085:Acetates / Q000627:therapeutic use*; D000588:Amines; D000927:Anticonvulsants / Q000627:therapeutic use*; D018692:Antimanic Agents / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy*; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D003509:Cyclohexanecarboxylic Acids; D000077206:Gabapentin; D006801:Humans; D000077213:Lamotrigine; D016651:Lithium Carbonate / Q000627:therapeutic use; D013973:Thyrotropin-Releasing Hormone / Q000627:therapeutic use; D014227:Triazines / Q000627:therapeutic use*; D005680:gamma-Aminobutyric Acid
D000085:Acetates; D000588:Amines; D000927:Anticonvulsants; D018692:Antimanic Agents; D002121:Calcium Channel Blockers; D003509:Cyclohexanecarboxylic Acids; D014227:Triazines; D016651:Lithium Carbonate; D005680:gamma-Aminobutyric Acid; D013973:Thyrotropin-Releasing Hormone; D000077206:Gabapentin; D000077213:Lamotrigine